PNEUMOCONIOSIS

Clinical trials for PNEUMOCONIOSIS explained in plain language.

Never miss a new study

Get alerted when new PNEUMOCONIOSIS trials appear

Sign up with your email to follow new studies for PNEUMOCONIOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Major trial launches for incurable Miner's lung disease

Disease control Recruiting now

This study is testing whether a drug called pirfenidone can help people with pneumoconiosis, a serious lung disease caused by dust inhalation. Over 52 weeks, 272 patients will take either the drug or a placebo pill to see if it can slow the decline in their lung function. The goa…

Matched conditions: PNEUMOCONIOSIS

Phase: PHASE3 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control

Last updated Mar 05, 2026 14:00 UTC

PNEUMOCONIOSIS

Get alerted when new PNEUMOCONIOSIS trials appear

Major trial launches for incurable Miner's lung disease